UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

Journal of psychiatric research, 2019-04, Vol.111, p.59-67

2019

Volltextzugriff (PDF)

Enhanced Adoption of Measurement-Based Care in a Psychiatry Outpatient Clinic After High-Reliability Process Changes

Psychiatric services (Washington, D.C.), 2023-04, Vol.74 (4), p.423-426

2023

Volltextzugriff (PDF)

Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression

Journal of affective disorders, 2023-02, Vol.323, p.534-539

2023

Volltextzugriff (PDF)

Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

BMC psychiatry, 2021-12, Vol.21 (1), p.622-622, Article 622

2021

Volltextzugriff (PDF)

Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

BMC psychiatry, 2022-06, Vol.22 (1), p.388-388, Article 388

2022

Volltextzugriff (PDF)

Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

BMC psychiatry, 2022-03, Vol.22 (1), p.170-170, Article 170

2022

Volltextzugriff (PDF)

Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis

Molecular psychiatry, 2022-09, Vol.27 (9), p.3658-3669

2022

Volltextzugriff (PDF)

The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study

Journal of affective disorders, 2018-02, Vol.227, p.542-549

2018

Volltextzugriff (PDF)

Impact of COVID-19 on electroconvulsive therapy practice across Canadian provinces during the first wave of the pandemic

BMC psychiatry, 2023-05, Vol.23 (1), p.327-327, Article 327

2023

Volltextzugriff (PDF)

A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study

Scientific reports, 2023-09, Vol.13 (1), p.15300-15300, Article 15300

2023

Volltextzugriff (PDF)

The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction

Current pharmaceutical design, 2012, Vol.18 (36), p.5976-5989

2012

Volltextzugriff (PDF)

Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2014-06, Vol.165B (4), p.303-313

2014

Volltextzugriff (PDF)

Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey

BMC psychiatry, 2023-06, Vol.23 (1), p.464-464, Article 464

2023

Volltextzugriff (PDF)

Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1

BMC medical genetics, 2014-01, Vol.15 (1), p.2-2, Article 2

2014

Volltextzugriff (PDF)

An evaluation of large group cognitive behaviour therapy with mindfulness (CBTm) classes

BMC psychiatry, 2019-05, Vol.19 (1), p.132-132, Article 132

2019

Volltextzugriff (PDF)

Reflections on Integrating a Therapist-guided CBT Website Into Routine Clinical Practice

Journal of psychiatric practice, 2024-09, Vol.30 (5), p.357-359

2024

Volltextzugriff (PDF)

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response

Translational psychiatry, 2021-08, Vol.11 (1), p.439-439, Article 439

2021

Volltextzugriff (PDF)

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments

Canadian journal of psychiatry, 2016-09, Vol.61 (9), p.561-575

2016

Volltextzugriff (PDF)

Mental Health in the Workplace: Strategies and Tools to Optimize Outcomes

1, 2019

Volltextzugriff (PDF)

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments

Canadian journal of psychiatry, 2016-09, Vol.61 (9), p.576-587

2016

Volltextzugriff (PDF)

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care

Canadian journal of psychiatry, 2016-09, Vol.61 (9), p.510-523

2016

Volltextzugriff (PDF)

Understanding and Addressing Mental Health Disorders: a Workplace Imperative

Current psychiatry reports, 2023-10, Vol.25 (10), p.455-463

2023

Volltextzugriff (PDF)

Adapting the Goal Attainment Approach for Major Depressive Disorder

Neurology and therapy, 2019-12, Vol.8 (2), p.167-176

2019

Volltextzugriff (PDF)

E-health: an overview of the uses of the Internet, social media, apps, and websites for mood disorders

Current opinion in psychiatry, 2015-01, Vol.28 (1), p.13-17

2015

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Aktive Filter

ThemaAntidepressants

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(187)
Mit Volltextzugriff
(191)

Publikationsform

Artikel
(195)
Buchkapitel
(21)
Reviews
(2)
Bücher
(1)

Sprache

Englisch
(219)

Erscheinungsjahr

n.n

Thema

Science & Technology
(139)
Life Sciences & Biomedicine
(137)
Psychiatry
(134)
Humans
(111)
Adult
(54)
Female
(50)
Male
(48)
Bipolar Disorder
(47)
Middle Aged
(37)
Neurosciences & Neurology
(37)
Depression
(35)
Mental Depression
(35)
Clinical Neurology
(32)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Psychology. Psychoanalysis. Psychiatry
(26)
Psychopathology. Psychiatry
(24)
Major Depressive Disorder
(23)
Canada
(22)
Depressive Disorder, Major - Drug Therapy
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

Enhanced Adoption of Measurement-Based Care in a Psychiatry Outpatient Clinic After High-Reliability Process Changes

Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression

Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis

The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study

Impact of COVID-19 on electroconvulsive therapy practice across Canadian provinces during the first wave of the pandemic

A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study

The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction

Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes

Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey

Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1

An evaluation of large group cognitive behaviour therapy with mindfulness (CBTm) classes

Reflections on Integrating a Therapist-guided CBT Website Into Routine Clinical Practice

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments

Mental Health in the Workplace: Strategies and Tools to Optimize Outcomes

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care

Understanding and Addressing Mental Health Disorders: a Workplace Imperative

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013

Adapting the Goal Attainment Approach for Major Depressive Disorder

E-health: an overview of the uses of the Internet, social media, apps, and websites for mood disorders

Aktive Filter

Suchergebnisse filtern